Trial matching for every case, before the board meets.
During prep, each case is screened against the trials the program has open. A missing criterion becomes a task before the meeting. The match is on the agenda, screening leaves the meeting with an owner and a date, and enrollment is on the record with the pathway status.
Trial candidates on the agenda and in the decision record.
The agenda row says trial candidate. The board decides the treatment and whether to screen, and the coordinator records both at the table: the screening task to the research coordinator with a due date, the consent discussion to the treating physician at the next visit.
Synthetic cases and figures. Patient details invented.
Screening and enrollment tracked as tasks.
From flag to screening visit to enrollment, each step is a task on someone's list. The quarter's figures show where cases stop, and the cases that stopped are named, so the program can close the gap between matched and screened.
Synthetic cases and figures. Patient details invented.
Trial access at community sites.
Most cancer patients are treated in the community, where trials are scarce. Arca's network opens trials at community sites where it can, and where it cannot, the referral to the trial site is a task with a date and a ride, and the trial visits join the patient's task list.
Synthetic cases and figures. Patient details invented.
Arca's other capabilities.
Each one works from the same decision record. How it works
Tell us where your oncology risk sits.
Which contracts, which sites, and who manages the follow-through today. We reply within two business days with how Arca would run alongside them, starting with one program.